MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Stock Option (right to buy)
2023-02-02+1,093,831→ 1,093,831 totalExercise: $1.78Exp: 2033-02-02→ Voting Common Stock (1,093,831 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on February 2, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.